This series of live workshops will cover the importance of LAG-3 as a new immunotherapy target and the emerging data on the mechanism of action, use, and safety of anti–LAG-3 immunotherapies across a range of malignancies. Accompanying these workshops will be a downloadable slideset, simulcasts, an expert commentary, a PDF practice resource, and an on-demand webcast.
Webinar 1 - June 28, 2022
Webinar 2 - July 6, 2022
Webinar 3 - July 19, 2022
Watch this on-demand webcast of a live webinar to gain expert insights on the safety and efficacy of anti–LAG-3 immunotherapies in the management of various solid tumors.